Relevance of FcγRIIIa-158V-F polymorphism to recurrence of adult periodontitis in Japanese patients

Clinical and Experimental Immunology

Volumn 117, Issue 2, 1999, Pages 350-354

  Sugita, N ^a   Yamamoto, K ^a   Kobayashi, T ^a   Van Der Pol, W L ^a,b   Horigome, T ^a   Yoshie, Hiromasa ^a   Van De Winkel, J G J ^a,b   Hara, K ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

158V F Fc R; Fc RIIIa; Polymorphism adult periodontitis

Indexed keywords

CD16 ANTIGEN;

ADULT; ADULT DISEASE; AGED; ARTICLE; ASIAN; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIODONTITIS; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION;

ADULT; AGE FACTORS; AGED; ALLELES; AMINO ACID SUBSTITUTION; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PERIODONTITIS; PHENYLALANINE; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RECURRENCE; VALINE;

EID: 0032816810     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00984.x     Document Type: Article

References (37)

1. 1 van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993; 14:215-21.
2. 2 van der Pol W-L, van de Winkel JGJ. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 1998; 48:222-32.
3. 3 Parren PWHI, Warmerdam PAM, Boeije LCM et al. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of functional polymorphism to human IgG2. J Clin Invest 1992; 90:1537-46.
4. 4 Salmon JE, Edberg JC, Kimberly RP. Fcγ receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J Clin Invest 1990; 85:1287-95.
5. 5 Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 1992; 89:1274-81.
6. 6 Vance BA, Huizinga TWJ, Wardwell K, Guyre PM. Binding of monomeric human IgG defines an expression polymorphism of FcγRIII on large granular lymphocyte/natural killer cells. J Immunol 1993; 151:6429-39.
7. 7 Braakman E, van de Winkel JGJ, van Krimpen BA, Jansze M, Bolhuis RLH. CD16 on human γδ T lymphocytes: expression, function, and specificity for mouse IgG isotypes. Cell Immunol 1992; 143:97-107.
8. 8 Perussia B, Trinchieri G, Jackson A, Warner NL, Faust J, Rumpold H, Kraft D, Lanier LL. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol 1984; 133:180-8.
9. 9 Park J-G, Isaacs RE, Chien P, Schreiber AD. In the absence of other Fc receptors, FcγRIIIA transmits a phagocytic signal that requires the cytoplasmic domain of its γ subunit. J Clin Invest 1993; 92:1967-73.
10. 10 Sulica A, Metes D, Gherman M, Whiteside TL, Herberman RB. Divergent effects of FcγRIIIA ligands on the functional activities of human natural killer cells in vitro. Eur J Immunol 1996; 26:1199-203.
11. 11 Marsh CB, Lowe MP, Rovin BH, Parker JM, Liao Z, Knoell DL, Wewers MD. Lymphocytes produce IL-1β in response to Fcγ receptor cross-linking: effects on parenchymal cell IL-8 release. J Immunol 1998; 160:3942-8.
12. 12 Lenz P, Gessner JE, Sautes C, Schmidt RE. Fc gamma-receptor III (CD16) is involved in NK-B cell interaction. Immunobiol 1996; 196:387-98.
13. 13 Ravetch JV, Perussia B. Alternative membrane forms of FcγRIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med 1989; 170:481-97.
14. 14 Koene HR, Kleijer M, Algra J, von Roos D, dem Borne AEG Kr, de Haas M. FcγRIIIa-158V/F polymorphism influences the binding of IgG by NK cell FcγRIIIa, independently of the FcγRIIIa-48L/R/H phenotype. Blood 1997; 90:1109-14.
15. 15 Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, Salmon JE, Kimberly RP. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100:1059-70.
16. 16 Koene HR, Kleijer M, Swaak AJG et al. The FcγRIIIA-158F allele is a risk factor for systemic lupus crythematosus. Arthritis Rheum 1998; 41:1813-8.
17. 17 Hirschfeld L, Wasserman B. A long-term survey of tooth loss in 600 treated periodontal patients. J Periodontol 1978; 49:225-37.
18. 18 McFall WT Jr. Tooth loss in 100 treated patients with periodontal disease. A long-term study. J Periodontol 1982; 53:539-49.
19. 19 Kornman KS, Crane A, Wang H-Y et al. The interleukin-I genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 24:72-77.
20. 20 Hart TC, Kornman KS. Genetic factors in the pathogenesis of periodontitis. Periodontology 2000 1997; 14:202-15.
21. 21 Sugita N, Suzuki T, Yoshie H, Yoshida N, Adachi M, Hara K. Differential expression of CR3, FcεRII and FcγRIII on polymorpho-nuclcar leukocytes in gingival crevicular fluid. J Periodont Res 1993; 28:363-72.
22. 22 Kobayashi T, Westerdaal NAC, Miyazaki A, van der Pol W-L, Suzuki T, Yoshie H, van de Winkel JGJ, Hara K. Relevance of immunoglobulin G Fc receptor polymorphism to recurrence of adult periodontitis in Japanese patients. Infect Immun 1997; 65:3556-60.
23. 23 Topoll HH, Zwadlo G, Lange DE, Sorg C. Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis. J Periodont Res 1989; 24:106-12.
24. 24 Matsuki Y, Yamamoto T, Hara K. Interleukin-1 mRNA-expressing macrophages in human chronically inflamed gingival tissues. Am J Pathol 1991; 138:1299-305.
25. 25 Schlegel Gómez R, Langer P, Pelka M, von den Driesch P, Johannessen AC, Simon M Jr. Variational expression of functionally different macrophage markers (27E10, 25F9, RM3/1) in normal gingiva and inflammatory periodontal disease. J Clin Periodontol 1995; 22:341-6.
26. 26 Wynne SE, Walsh LJ, Seymour GJ, Powell RN. In situ demonstration of natural killer (NK) cells in human gingival tissue. J Periodontol 1986; 57:699-702.
27. + (Leu-7) cells and natural killer cell activity in inflamed human gingival tissue. J Oral Pathol 1988; 17:118-23.
28. +) populations in clinically healthy gingiva, chronic gingivitis and chronic adult periodontitis. J Periodont Res 1989; 24:1-7.
29. 29 Cobb CM, Singla O, Theisen FC, Shultz RE. Ultrastructural evidence of large granular lymphocyte (LGL) activity in lesions of chronic adult periodontitis. J Clin Periodontol 1990; 17:371-8.
30. 30 Gemmel E, Seymour GJ. γδ T Lymphocytes in human periodontal disease tissue. J Periodontol 1995; 66:780-5.
31. 31 Kinane DF, Lappin DF, Koulouri O, Buckley A. Humoral immune responses in periodontal disease may have mucosal and systemic immune features. Clin Exp Immunol 1999; 115:534-41.
32. 32 Colombo AP, Eftimiadi C, Haffajee AD, Cugini MA, Socransky SS. Serum IgG2 level, Gm (23) allotype and FcγRIIa and FcγRIIIb receptors in refractory periodontal disease. J Clin Periodontol 1998; 25:465-74.
33. 33 Hibbs ML, Tolvanen M, Carpén O. Membrane-proximal Ig-like domain of FcγRIII (CD16) contains residues critical for ligand binding. J Immunol 1994; 152:4466-74.
34. 34 Tamm A, Schmidt RE. The binding epitopes of human CD16 (FcγRIII) monoclonal antibodies. Implications for ligand binding. J Immunol 1996; 157:1576-81.
35. 35 Edberg JC, Kimberly RP. Cell type-specific glycoforms of FcγRIIIa (CD16). Differential ligand binding. J Immunol 1997; 159:3849-57.
36. 36 Afar B, Engel D, Clark EA. Activated lymphocyte subsets in adult periodontitis. J Periodont Res 1992; 27:126-33.
37. 37 Anderson CL, Looney RJ, Culp DJ et al. Alveolar and peritoneal macrophages bear three distinct classes of Fc receptors for IgG. J Immunol 1990; 145:196-201.